48 results on '"de Bellis, M"'
Search Results
2. SC115 - Initial experience of ileal hetherotopic reservoir with catheterizable ileal conduit as an alternative to orthotopic ileal neobladder
3. VP.86 Effect of a chronic treatment with L-citrulline on funtional, histological and molecular readouts of dystrophic mdx mouse model
4. VP.84 Growth hormone secretagogues in Duchenne muscular dystrophy: a preclinical evaluation of potential benefits on muscle function and morphology
5. Portal vein stenting in recurrent or advanced perihilar cholangiocarcinoma.
6. V75 - Radical cystectomy in renal transplant recipients: The advantages of the robotic approach
7. V54 - Three-dimensional digital models in kidney cancer surgery: Results and video-illustrated technique of an institutional series
8. V05 - First ever reported case of continuous spinal anesthesia da Vinci robotic partial nephrectomy
9. SC46 - 3D vs non 3D reconstruction in nephron sparing surgery: a retrospective analysis
10. DMD – ANIMAL MODELS: EP.92 Growth hormone secretagogues in Duchenne muscular dystrophy: preclinical proof-of-concept in vivo and in vitro assays
11. DMD – ANIMAL MODELS: EP.80 ``Of Mice and Measures'': a natural history study of the D2-mdx mouse model to improve translational research for Duchenne muscular dystrophy
12. P0731 - Skeletal muscle loss predicts oncological outcomes in T1HG patients treated with adjuvant intravesical BCG: Implications for decision-making?
13. T.12.4: COMPARISON BETWEEN TRANSIENT ELASTOGRAPHY AND POINT-SHEARWAVE IN NON-ALCOHOLIC STEATOHEPATITS PATIENTS: A PROSPECTIVE STUDY.
14. DMD – ANIMAL MODELS & PRECLINICAL TREATMENT: P.222 Skeletal and cardiac muscle dysfunction in the D2-mdx mouse model of Duchenne muscular dystrophy: a comparison with BL10-mdx mice using TREAT-NMD SOPs
15. DMD – ANIMAL MODELS & PRECLINICAL TREATMENT: P.211 Src tyrosine kinase as potential target in Duchenne muscular dystrophy: assessment of a novel dasatinib formulation in the mdx mouse model
16. MUSCLE FUNCTION & HOMEOSTASIS / MOLECULAR THERAPEUTIC APPROACHES: P.76 Validation of in vivo and ex vivo readouts in a murine model of hind limb unloading to optimize translational research on skeletal muscle atrophy
17. Safinamide effects on skeletal muscle sodium channels and models of non-dystrophic myotonia (NDM) compared to mexiletine: Exploring potential for clinical utility
18. P.315Src tyrosine kinase as a drug target in Duchenne muscular dystrophy: a proof-of-concept study in the exercised mdx mouse
19. P.317 - Src tyrosine kinase as potential drug target in Duchenne muscular dystrophy: in vivo and in vitro preclinical studies
20. T.07.9 EFFECT OF METRONIDAZOLE RESISTANCE ON HELICOBACTER PYLORI ERADICATION REGIMENS.
21. Is Serum D-lactate a New Biomarker of Postoperative Complications after Liver Resection?
22. P4.45 Evaluation of the dual action of new derivatives of mexiletine as use-dependent sodium channel blockers and antioxidant: potential therapeutic application in neuromuscular disorders
23. G.P.14.11 Newly synthesized mexiletine and tocainide analogues are potent use-dependent blockers of skeletal muscle sodium channels: Potential implication for the antimyotonic activity
24. Percutaneous ablation in perivascular-HCC: impact of liver parenchyma and characteristics of vascular structures on the outcomes.
25. Major pancreatic resection in Jehovah's witness patients: a single institute experience.
26. Development and internal validation of a tool to predict early recurrence after surgery in peri-hilar cholangiocarcinoma: preoperative recurrence score.
27. P.12.7: Management of Resection and Intra-Procedural Complications of Large Colonic Lesions in a Real-Life Setting: The Scalp Study.
28. OC.02.5: Periendoscopic Management of Direct Oral Anticoagulants: A Prospective Cohort Study.
29. OC.08.9 IMPLEMENTING SPLIT REGIMEN OVER SINGLE DOSE (IMPROVES): A QUALITY IMPROVEMENT (QI) PROJECT TO IMPROVING BOWEL PREPARATION IN CLINICAL PRACTICE. PRELIMINARY RESULTS FROM SIED CAMPANIA NETWORK.
30. OC.21.6 DO K-RAS MUTATION STATUS AND ANTI-TUMORAL THERAPIES INFLUENCE THE RISK OF SEMS-RELATED COMPLICATIONS IN PATIENTS WITH OBSTRUCTIVE COLORECTAL CANCER?
31. P.17.7 USEFULNESS OF NONCATHARTIC CT COLONOGRAPHY WITH FECAL TAGGING FOR THE SURVEILLANCE OF HNPCC FAMILY MEMBERS. PRELIMINARY DATA.
32. OC.01.1 ENDOSCOPIC TRAINING DURING THE GASTROENTEROLOGY FELLOWSHIP IN ITALY. RESULTS OF A NATIONAL SURVEY.
33. P.1.257: A MULTICENTER PROSPECTIVE STUDY OF MANAGEMENT OF INOPERABLE MALIGNANT ESOPHAGEAL STRICTURES WITH A NEW FULLY COVERED METAL STENT.
34. CS.2.7 PALLIATIVE ENDOSCOPIC TREATMENT BY SELF EXPANDING METAL STENT (SEMS) IN PATIENTS WITH INOPERABLE MALIGNANT COLORECTAL OBSTRUCTION. ANALYSIS OF RESULTS AND PREDICTORS OF OUTCOMES IN A LARGE MULTICENTER SERIES.
35. EXPANDABLE METAL STENTS FOR PALLIATION OF MALIGNANT GASTRIC OUTLET OBSTRUCTION. REPORT OF 23 CONSECUTIVE PATIENTS TREATED IN A CANCER CENTER.
36. Expandable metal stents for palliation of malignant colorectal obstruction. Report of 20 consecutive patients.
37. A prospective evaluation of EUS in the preoperative staging and restaging after neoadjuvant chemo-radiation of patients with rectal cancer.
38. A prospective blinded assessment of the impact of preoperative EUS plus MRI on the management of locally advanced rectal cancer.
39. A prospective comparison of polyflex and ultraflex stents for palliation of inoperable malignant esophageal strictures. Preliminary report.
40. 1534TiP Valproic acid combinEd with Simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic Pancreatic Adenocarcinoma patients-VESPA trial.
41. 3D Hyper Accuracy 3DTM Surgical Simulation for Planning Complex Liver Resections: A Preliminary Single Center Experience.
42. A1023 - Usefulness of three-dimensional reconstruction during nephron sparing surgery: A retrospective single institution analysis.
43. A0720 - Clinical validation of the EAU2021 intermediate risk NMIBC definition and implications for adjuvant treatment: A multicenter YAU Urothelial Collaboration.
44. Three-dimensional (3D) Models Based on Pre-operative Computed Tomography Scans to Personalize the Planned Liver Surgery in Complex Cases.
45. Ablation Difficult Score: Proposal of a New Tool to Predict Success Rate of Ablation for HCC.
46. Factors Related to Textbook Outcome in Laparoscopic Liver Resections: A Single Western Center Analysis.
47. A New Tool to Predict Success Rate of Percutaneous Ablation for HCC: The Ablation Difficulty Score.
48. Infective Complications Following Liver Surgery for Perihilar-cholangiocarcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.